Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differences in Blood and Cerebrospinal Fluid Between Parkinson’s Disease and Related Diseases

27 Dec 2024

Abstract excerpt

It is difficult to distinguish Parkinson's disease (PD) in the early stage from those of various disorders including atypical Parkinson's syndrome (APS), vascular parkinsonism (VP), and even essential tremor (ET), because of the overlap of symptoms. Other, more challenging problems will arise when Parkinson's disease develops into Parkinson's disease dementia (PDD) in the middle and late stages. At this time, the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurological diseases and metabolism
Share to Neurological disorders and treatments
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39729132
DOI: 10.1007/s10571-024-01523-z

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differences in Blood and Cerebrospinal Fluid Between Parkinson’s Disease and Related DiseasesPMID 39729132Read ↗

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s diseaseSemantic proximity Read ↗

Parkinson's disease--the continuing search for biomarkers.Semantic proximity Read ↗

Diagnostic biomarkers for Parkinson's disease at a glance: where are we?Semantic proximity Read ↗

Parkinson’s Disease: Biomarkers, Treatment, and Risk FactorsSemantic proximity Read ↗

From phenotype to biology: a multi-modal roadmap of biofluid, tissue, imaging, and digital biomarkers in Parkinson's disease.Semantic proximity Read ↗

The Many Faces of Parkinsonism: Dissecting Clinical and Molecular Overlap in Multiple System Atrophy and Parkinson's DiseaseSemantic proximity Read ↗

Parkinson DiseaseSemantic proximity Read ↗

Cerebrospinal fluid biomarker for Parkinson's disease: An overviewSemantic proximity Read ↗

Parkinson's disease.Semantic proximity Read ↗

Cerebrospinal Fluid Biomarker Candidates for Parkinsonian DisordersSemantic proximity Read ↗

Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical featuresSemantic proximity Read ↗

Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.